Within EU-funded Horizon 2020 projects, ‘Deliverables’ are “outputs that must be produced at a given moment” during the project. This includes, for example, detailed information on the scientific progress of a specific task, a research manuscript, a special report, a technical diagram, a brochure, a software, or another important “building block”. As soon as such a deliverable has been completed, a detailed deliverable report is required to be submitted to and checked by the European Commission (EC). REPO-TRIAL dissemination items are openly available for download here. In addition, feel free to view our public deliverable reports:

WP1 – Data integration and in silico trial prediction

• Deliverable Report D1.1 – Diseasome 2.0 network (PDF | 592 KB)
• Deliverable Report D1.6 – Software for detection of pathway co-enrichment for extracting of patient(group)-specific pathways also enriched in target sites of effective drugs (PDF | 450 KB)
• Deliverable Report D1.8 – Drugome 1.0 network (PDF | 590 KB)
• Deliverable Report D1.10 – Refined diseasome and drugome 3.5 (PDF | 2 MB)

WP2 – Pre-clinical validation of in-silico trial predictions

• Deliverable Report D2.6 – Publish an open preclinical biobank for preclinical animal models related commROCG and other disease phenotypes for both genders (PDF | 985 KB)

WP3 – Clinical validation of in-silico trial prediction

(Downloads available soon)

• Deliverable Report D3.7 – Publication on study design, study protocol and start: pilot study 1: STROKE
• Deliverable Report D3.8 – Publication on study design, study protocol and start: pilot study 2: HFPEF
• Deliverable Report D3.9 – Publication on results of pilot study 1: STROKE
• Deliverable Report D3.10 – Publication on results of pilot study 2: HFPEF
• Deliverable Report D3.11 – Manuscript on two to three clinical drug repurposing trials on commROCG phenotypes and targets completed
• Deliverable Report D3.12 – Manuscript on Improved understanding of REPO-TRIAL biomarker panels as early predictors of efficacy
• Deliverable Report D3.13 – Manuscript on improved understanding of the clinical significance of REPO-TRIAL mechanisms and targets to explain comorbidities in both genders
• Deliverable Report D3.14 – Manuscript on new directions for in-silico trialling and improved clinical development

WP4 – Dissemination and Exploitation of Results

• Deliverable Report D4.2 – Communication and dissemination plan (PDF | 664 KB)
• Deliverable Report D4.3 – Project brochure and professional templates (PDF | 1,52 MB)